- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Mary Norine Walsh on Being Your Own Advocate
Mary Norine Walsh, MD, immediate past president of the American College of Cardiology, discusses the importance of women being their own advocate when receiving postpartum care.
Transcript
During your address at the American College of Cardiology meeting this year, you talked about the importance of being your own advocate in the healthcare system. How does that message apply to women in receiving postpartum care?
Well, when a woman is receiving postpartum care, being her own advocate is asking to know, 'What is my blood pressure, what is my weight, what would you advise my weight to be? Did I develop gestational hypertension or diabetes during my pregnancy?' Understanding her own history is really a way for a woman to advocate for herself.
Importantly, if she's not receiving that information from the clinician she's seeing, seeking that information with a different clinician.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Finding the Right Biomarker Is Key to the TIGIT Puzzle, Experts Say
May 12th 2025Data for SKYSCRAPER-01, involving the anti-TIGIT antibody tiragolumab, align with recent bad news for this once-promising therapeutic target. But investigators involved in TIGIT studies say the problem is finding the right biomarker.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Addressing KRAS Resistance, RAS(ON) Therapies Find Limelight at AACR
May 5th 2025KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, as highlighted at the 2025 meeting of the American Association for Cancer Research (AACR).
Read More
